Overview
- 179 inspections across 156 sites are on record.
- 655 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-11-07.
At a glance
Inspections
179
Sites
156
Observations
655
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pharmedica USA, LLC | 7 Nov 2022 | Human Drugs | View 483 → |
| Apnar Pharma Private Limited | 16 Sep 2022 | Human Drugs | View 483 → |
| Ajanta Pharma Limited | 9 Sep 2022 | Human Drugs | View 483 → |
| GoodFibers LLC | 19 Aug 2022 | Human Drugs | View 483 → |
| Centrient Pharmaceuticals India Private Limited | 1 Jul 2022 | Human Drugs | On file |
Sites inspected
Pharmedica USA, LLCPhoenix, United States1 insp.
Apnar Pharma Private LimitedTal Padra, Vadodara, India1 insp.
Ajanta Pharma LimitedBharuch, India1 insp.
GoodFibers LLCPhoenix, United States1 insp.
Centrient Pharmaceuticals India Private LimitedNawashahr, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Catherine M Hollman10 shared
Sandra A Hughes8 shared
Kimberly W Destromp7 shared
Jean M Bosenbecker6 shared
Christina A Castineyra6 shared
Jessica L Barr5 shared
Nicole C Shokatz5 shared
Gavin T Cua4 shared
Peter T Erlandson4 shared
Katherine A Clarke Girolamo4 shared
Full investigator report
Get the verbatim findings behind Joel D Hustedt's 655 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site